Pre-made Bapotulimab benchmark antibody ( Whole mAb, anti-ILDR2 therapeutic antibody, Anti-C1orf32/dJ782G3.1 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Bapotulimab biosimilar, Whole mAb, Anti-ILDR2 Antibody: Anti-C1orf32/dJ782G3.1 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Bapotulimab is a human/mouse cross-reactive immunoglobulin G2 (IgG2) monoclonal antibody that exhibits anti-tumour activity by targeting, binding to and inhibiting ILDR2, and thereby blocking the immunosuppressive activity of ILDR2.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	List Price(In USD)	Discount off	Discount Price
GMP-Bios-ab-047-1mg	1mg	3090	Inquiry	Inquiry

Size： 1mg | 10mg | 100mg

Description

Products Name (INN Index)	Pre-Made Bapotulimab biosimilar, Whole mAb, Anti-ILDR2 Antibody: Anti-C1orf32/dJ782G3.1 therapeutic antibody
INN Name	Bapotulimab
Target	ILDR2
Format	Whole mAb
Derivation
Species Reactivity	Human
CH1 Isotype	IgG2
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Phase-I
Est. Status	Active
100% SI Structure	None
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2020
Year Recommended	2021
Companies	Bayer
Conditions Approved	na
Conditions Active	Solid tumours
Conditions Discontinued	na
Development Tech	na